RELATED STUDY
Future Aspects for Cannabinoids in Breast Cancer Therapy
Key Findings: Cannabinoids are promising agents for inhibiting breast cancer progression. However,to develop safe therapeutic drugs, a further examination of the molecular pathways associated with cannabinoid activities is required.
Type of Study: Meta-analysis
Study Result: Positive
Study Location(s): Austria, Slovakia
Year of Pub: 2019
Cannabinoids Studied: Cannabidiol (CBD), Cannabigerol (CBG), Tetrahydrocannabinol (THC), Cannabinol (CBN), Cannabidiolic Acid (CBD-a), Tetrahydrocannabinolic Acid (THC-a), AM-x Synthetic Cannabinoids, O-x Synthetic Cannabinoids, WIN-x Synthetic Cannabinoids, Anandamide (AEA), Fatty Acid Amide Hydrolase (FAAH), 2-Arachidonoyl Glycerol (2-AG), Monoacylglycerol Lipase (MAGL), Pharma THC, Pharma THC:CBD, Tetrahydrocannabivarin (THCV)
Receptors Studied: CB1, CB2, GPCR 18, GPCR 55, TRPV1, PPAR - Gamma
